You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Treating Human Autoimmunity: Current Practice and Future Prospects
|
|---|---|
| Published in |
Science Translational Medicine, March 2012
|
| DOI | 10.1126/scitranslmed.3003504 |
| Pubmed ID | |
| Authors |
Michael D. Rosenblum, Iris K. Gratz, Jonathan S. Paw, Abul K. Abbas |
| Abstract |
Autoimmune diseases are caused by immune cells attacking the host tissues they are supposed to protect. Recent advances suggest that maintaining a balance of effector and regulatory immune function is critical for avoiding autoimmunity. New therapies, including costimulation blockade, regulatory T cell therapy, antigen-specific immunotherapy, and manipulating the interleukin-2 pathway, attempt to restore this balance. This review discusses these advances as well as the challenges that must be overcome to target these therapies to patients suffering from autoimmune disease while avoiding the pitfalls of general immunosuppression. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 20% |
| United States | 2 | 20% |
| Canada | 1 | 10% |
| United Arab Emirates | 1 | 10% |
| Unknown | 4 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 90% |
| Scientists | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 310 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| United Kingdom | 1 | <1% |
| Mexico | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 305 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 62 | 20% |
| Student > Bachelor | 47 | 15% |
| Researcher | 39 | 13% |
| Other | 24 | 8% |
| Student > Master | 24 | 8% |
| Other | 47 | 15% |
| Unknown | 67 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 52 | 17% |
| Biochemistry, Genetics and Molecular Biology | 50 | 16% |
| Immunology and Microbiology | 45 | 15% |
| Medicine and Dentistry | 41 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 5% |
| Other | 33 | 11% |
| Unknown | 74 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 779. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#23,998
of 25,059,640 outputs
Outputs from Science Translational Medicine
#96
of 5,384 outputs
Outputs of similar age
#68
of 161,573 outputs
Outputs of similar age from Science Translational Medicine
#1
of 78 outputs
Altmetric has tracked 25,059,640 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,384 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 86.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.